166 related articles for article (PubMed ID: 35181932)
21. COVID-19: vaccination vs. hospitalization.
Uzun O; Akpolat T; Varol A; Turan S; Bektas SG; Cetinkaya PD; Dursun M; Bakan N; Ketencioglu BB; Bayrak M; Baris SA; Guner R; Gunal O; Nural S; Deniz PP; Toprak OB; Ozkan G; Gumus A; Kerget F; Ercelik M; Ataoglu O; Yuksel A; Ates G; Kutsoylu OE; Kose N; Kizilirmak D; Keskin S; Gultekin O; Coskun N; Yilmaz ES; Uslu S; Basyigit İ; Ergan B; Deveci F; Yakar MN; Zuhur C; Sagcan G; Yuce ZT; Kuluozturk M; Sezgin ME; Sezgin ENA; Havlucu Y; Cuhadaroglu C; Kilinc O; Boyaci H; Altunay H; Akti M; Dursun ZB; Kalem AK; Isik SA; Akyildiz L; Aykac N; Almaz MS; Kokturk N; Itil O
Infection; 2022 Jun; 50(3):747-752. PubMed ID: 34984646
[TBL] [Abstract][Full Text] [Related]
22. Response and Duration of Serum Anti-SARS-CoV-2 Antibodies After Inactivated Vaccination Within 160 Days.
Xu QY; Xue JH; Xiao Y; Jia ZJ; Wu MJ; Liu YY; Li WL; Liang XM; Yang TC
Front Immunol; 2021; 12():786554. PubMed ID: 35003104
[TBL] [Abstract][Full Text] [Related]
23. Waning immunity to inactive SARS-CoV-2 vaccine in healthcare workers: booster required.
Balkan İİ; Dinc HO; Can G; Karaali R; Ozbey D; Caglar B; Beytur AN; Keskin E; Budak B; Aydogan O; Mete B; Ergin S; Kocazeybek B; Saltoglu N
Ir J Med Sci; 2023 Feb; 192(1):19-25. PubMed ID: 35344137
[TBL] [Abstract][Full Text] [Related]
24. Antibody response following the third and fourth SARS-CoV-2 vaccine dose in individuals with common variable immunodeficiency.
Nielsen BU; Drabe CH; Barnkob MB; Johansen IS; Hansen AKK; Nilsson AC; Rasmussen LD
Front Immunol; 2022; 13():934476. PubMed ID: 35967433
[TBL] [Abstract][Full Text] [Related]
25. Association of Gestational Age at Coronavirus Disease 2019 (COVID-19) Vaccination, History of Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Infection, and a Vaccine Booster Dose With Maternal and Umbilical Cord Antibody Levels at Delivery.
Yang YJ; Murphy EA; Singh S; Sukhu AC; Wolfe I; Adurty S; Eng D; Yee J; Mohammed I; Zhao Z; Riley LE; Prabhu M
Obstet Gynecol; 2022 Mar; 139(3):373-380. PubMed ID: 34963127
[TBL] [Abstract][Full Text] [Related]
26. Evaluation of the SARS-CoV-2 Antibody Response to the BNT162b2 Vaccine in Patients Undergoing Hemodialysis.
Yau K; Abe KT; Naimark D; Oliver MJ; Perl J; Leis JA; Bolotin S; Tran V; Mullin SI; Shadowitz E; Gonzalez A; Sukovic T; Garnham-Takaoka J; de Launay KQ; Takaoka A; Straus SE; McGeer AJ; Chan CT; Colwill K; Gingras AC; Hladunewich MA
JAMA Netw Open; 2021 Sep; 4(9):e2123622. PubMed ID: 34473256
[TBL] [Abstract][Full Text] [Related]
27. Inactive SARS-CoV-2 vaccine generates high antibody responses in healthcare workers with and without prior infection.
Dinc HO; Saltoglu N; Can G; Balkan II; Budak B; Ozbey D; Caglar B; Karaali R; Mete B; Tuyji Tok Y; Ersoy Y; Ahmet Kuskucu M; Midilli K; Ergin S; Kocazeybek BS
Vaccine; 2022 Jan; 40(1):52-58. PubMed ID: 34839992
[TBL] [Abstract][Full Text] [Related]
28. Inactivated SARS-CoV-2 vaccine in primary Sjögren's syndrome: humoral response, safety, and effects on disease activity.
Pasoto SG; Halpern ASR; Guedes LKN; Ribeiro ACM; Yuki ENF; Saad CGS; da Silva CAA; de Vinci Kanda Kupa L; Villamarín LEB; de Oliveira Martins VA; Martins CCMF; Deveza GBH; Leon EP; Bueno C; Pedrosa TN; Santos REB; Soares R; Aikawa NE; Bonfa E
Clin Rheumatol; 2022 Jul; 41(7):2079-2089. PubMed ID: 35306594
[TBL] [Abstract][Full Text] [Related]
29. Impaired antibody response to inactivated COVID-19 vaccines in hospitalized patients with type 2 diabetes.
Zhou X; Lu H; Sang M; Qiu S; Yuan Y; Wu T; Chen J; Sun Z
Hum Vaccin Immunother; 2023 Dec; 19(1):2184754. PubMed ID: 36864628
[TBL] [Abstract][Full Text] [Related]
30. Reduced humoral immune response after BNT162b2 coronavirus disease 2019 messenger RNA vaccination in cancer patients under antineoplastic treatment.
Peeters M; Verbruggen L; Teuwen L; Vanhoutte G; Vande Kerckhove S; Peeters B; Raats S; Van der Massen I; De Keersmaecker S; Debie Y; Huizing M; Pannus P; Neven K; Ariën KK; Martens GA; Van Den Bulcke M; Roelant E; Desombere I; Anguille S; Goossens M; Vandamme T; van Dam P
ESMO Open; 2021 Oct; 6(5):100274. PubMed ID: 34597941
[TBL] [Abstract][Full Text] [Related]
31. Efficacy of antibody response following the vaccination of SARS-CoV-2 infected and noninfected healthcare workers by two-dose inactive vaccine against COVID-19.
Dundar B; Karahangil K; Elgormus CS; Topsakal HNH
J Med Virol; 2022 Jun; 94(6):2431-2437. PubMed ID: 35128700
[TBL] [Abstract][Full Text] [Related]
32. Comparison of SARS-CoV-2 antibody response after two doses of mRNA and inactivated vaccines in multiple sclerosis patients treated with disease-modifying therapies.
Ozakbas S; Baba C; Dogan Y; Cevik S; Ozcelik S; Kaya E
Mult Scler Relat Disord; 2022 Feb; 58():103486. PubMed ID: 35032878
[TBL] [Abstract][Full Text] [Related]
33. Impact of Distinct Therapies on Antibody Response to SARS-CoV-2 Vaccine in Systemic Lupus Erythematosus.
Yuki EFN; Borba EF; Pasoto SG; Seguro LP; Lopes M; Saad CGS; Medeiros-Ribeiro AC; Silva CA; de Andrade DCO; Kupa LVK; Betancourt L; Bertoglio I; Valim J; Hoff C; Formiga FFC; Pedrosa T; Kallas EG; Aikawa NE; Bonfa E
Arthritis Care Res (Hoboken); 2022 Apr; 74(4):562-571. PubMed ID: 34806342
[TBL] [Abstract][Full Text] [Related]
34. Waning of SARS-CoV-2 Vaccine-Induced Immune Response over 6 Months in Peritoneal Dialysis Patients and the Role of a Booster Dose in Maintaining Seropositivity.
Murt A; Dinc HO; Altiparmak MR; Yalin SF; Yadigar S; Parmaksiz E; Kocazeybek B; Pekpak M; Ataman MR
Nephron; 2022; 146(6):559-563. PubMed ID: 35598596
[TBL] [Abstract][Full Text] [Related]
35. Antibody Responses to BNT162b2 Vaccination in Japan: Monitoring Vaccine Efficacy by Measuring IgG Antibodies against the Receptor-Binding Domain of SARS-CoV-2.
Fujigaki H; Yamamoto Y; Koseki T; Banno S; Ando T; Ito H; Fujita T; Naruse H; Hata T; Moriyama S; Takahashi Y; Suzuki T; Murakami T; Yoshida Y; Yagura Y; Oyamada T; Takemura M; Kondo M; Iwata M; Saito K
Microbiol Spectr; 2022 Feb; 10(1):e0118121. PubMed ID: 35044205
[TBL] [Abstract][Full Text] [Related]
36. Antibody response with SARS-CoV-2 inactivated vaccine (CoronaVac) in Turkish geriatric population.
Okyar Baş A; Hafizoğlu M; Akbiyik F; Güner Oytun M; Şahiner Z; Ceylan S; Ünsal P; Doğu BB; Cankurtaran M; Çakir B; Ünal S; Halil MG
Age Ageing; 2022 May; 51(5):. PubMed ID: 35524745
[TBL] [Abstract][Full Text] [Related]
37. Antibody response to SARS-CoV-2 vaccines among hospitalized patients in China: a case-control study.
Li FP; Shi GF; Lin ZZ; Zhu XL; Wang LJ; Tung TH; Zhang MX
Hum Vaccin Immunother; 2022 Nov; 18(5):2088966. PubMed ID: 35708313
[TBL] [Abstract][Full Text] [Related]
38. The role of COVID-19 survivor status and gender towards neutralizing antibody titers 1, 2, 3 months after Sinovac vaccine administration on clinical-year medical students in Indonesia.
Heriyanto RS; Kurniawan A; Wijovi F; Halim DA; Jodhinata C; Marcella E; Susanto B; Wibowo J; Indrawan M; Heryadi NK; Imanuelly M; Anurantha JJ; Hariyanto TI; Marcellin C; Sinaga TD; Rizki SA; Sieto N; Siregar JI; Lugito NPH
Int J Infect Dis; 2021 Dec; 113():336-338. PubMed ID: 34653654
[TBL] [Abstract][Full Text] [Related]
39. Comparison of SARS-CoV-2 Antibody Response 4 Weeks After Homologous vs Heterologous Third Vaccine Dose in Kidney Transplant Recipients: A Randomized Clinical Trial.
Reindl-Schwaighofer R; Heinzel A; Mayrdorfer M; Jabbour R; Hofbauer TM; Merrelaar A; Eder M; Regele F; Doberer K; Spechtl P; Aschauer C; Koblischke M; Paschen C; Eskandary F; Hu K; Öhler B; Bhandal A; Kleibenböck S; Jagoditsch RI; Reiskopf B; Heger F; Bond G; Böhmig GA; Strassl R; Weseslindtner L; Indra A; Aberle JH; Binder M; Oberbauer R
JAMA Intern Med; 2022 Feb; 182(2):165-171. PubMed ID: 34928302
[TBL] [Abstract][Full Text] [Related]
40. Association of SARS-CoV-2 Spike Protein Antibody Vaccine Response With Infection Severity in Patients With Cancer: A National COVID Cancer Cross-sectional Evaluation.
Lee LYW; Tilby M; Starkey T; Ionescu MC; Burnett A; Hattersley R; Khan S; Little M; Liu JKH; Platt JR; Tripathy A; Watts I; Williams ST; Appanna N; Al-Hajji Y; Barnard M; Benny L; Buckley A; Cattell E; Cheng V; Clark J; Eastlake L; Gerrand K; Ghafoor Q; Grumett S; Harper-Wynne C; Kahn R; Lee AJX; Lydon A; McKenzie H; Panneerselvam H; Pascoe J; Patel G; Patel V; Potter V; Randle A; Rigg AS; Robinson T; Roylance R; Roques T; Rozmanowski S; Roux RL; Shah K; Sintler M; Taylor H; Tillett T; Tuthill M; Williams S; Beggs A; Iveson T; Lee SM; Middleton G; Middleton M; Protheroe AS; Fittall MW; Fowler T; Johnson P;
JAMA Oncol; 2023 Feb; 9(2):188-196. PubMed ID: 36547970
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
